UV Clinical A/S: Financial statements 2022
CVR: 38401572
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
UV Clinical A/S (CVR 38401572) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 150,952 and a net result of DKK -268,887 compared with DKK 2,248,332 the year before. That is an increase of 351.1% compared with the year before. Equity in the 2022 report amounted to DKK 1,677,043. The solvency ratio was 69.8%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 150,952
- Profit/Loss
- DKK -268,887
- Equity
- DKK 1,677,043
- Total Assets
- DKK 2,402,169
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 151K | -269K | 1.7M | 1 |
| 2021 | - | 33K | 2.2M | 124K | 1 |
| 2020 | - | -411K | -1.1M | -2.1M | 1 |
| 2019 | - | -577K | -1.4M | -975K | 1 |
| 2018 | - | 4K | -799K | -584K | 1 |
Official annual report
Keep an eye on UV Clinical A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
As of October 5, 2022, Emilio de la Guardia Gascuñana has joined the board of directors of UV Clinical A/S.
As of August 23, 2022, Jimmy Bak has joined the board of directors of UV Clinical A/S.
On August 23, 2022, the company changed its name from UV Clinical ApS to UV Clinical A/S.
As of July 5, 2022, Claus Frisenberg Pedersen has left the board of directors of UV Clinical A/S.
UV Clinical A/S has published its annual report for 2021. Gross profit came to DKK 33,464, and the net result was DKK 2,248,332.
As of March 25, 2022, Carsten Viftrup Andersen has left the board of directors of UV Clinical A/S.
About UV Clinical A/S
UV Clinical A/S is a Danish company of the type Aktieselskab based in Hellerup, founded in 2017. The company is registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil. The company was previously named UV Clinical ApS. The management consists of Rolf Henrik Sprunk-Jansen. The board consists of Helge Holm-Larsen (chair), Emilio de la Guardia Gascuñana and Rolf Henrik Sprunk-Jansen. The company is owned by Ulstrup Invest ApS, Canajo Invest ApS and Holafa ApS. The company has 3 employees (2026). In 2025, the company reported a gross profit of DKK 1,274,253 and a net result of DKK -1,282,165 compared with DKK -1,895,100 the year before. Equity in the 2025 report amounted to DKK 22,796,335.
